Literature DB >> 8416263

Ivermectin, an antiparasitic agent.

W C Campbell1.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8416263     DOI： 10.1002/med.2610130103

Source DB:  PubMed          Journal:  Med Res Rev        ISSN： 0198-6325            Impact factor:   12.944


× No keyword cloud information.
  11 in total

1.  Observations on topical ivermectin in the treatment of otoacariosis, cheyletiellosis, and toxocariosis in cats.

Authors:  N Pagé; C de Jaham; M Paradis
Journal:  Can Vet J       Date:  2000-10       Impact factor: 1.008

2.  Comparative pharmacokinetics of ivermectin alone and a novel formulation of ivermectin and rafoxanide in calves and sheep.

Authors:  H A El-Banna; A Goudah; H El-Zorba; S Abd-El-Rahman
Journal:  Parasitol Res       Date:  2008-02-23       Impact factor: 2.289

Review 3.  The challenges of developing novel antiparasitic drugs.

Authors:  Debra J Woods; Tracey M Williams
Journal:  Invert Neurosci       Date:  2007-11-15

4.  Improved antifilarial activity of ivermectin in chitosan-alginate nanoparticles against human lymphatic filarial parasite, Brugia malayi.

Authors:  Mohammad Ali; Mohammad Afzal; Meenakshi Verma; Shailja Misra-Bhattacharya; Farhan Jalees Ahmad; Amit Kumar Dinda
Journal:  Parasitol Res       Date:  2013-07-05       Impact factor: 2.289

5.  Topical (pour-on) ivermectin in the treatment of canine scabies.

Authors:  M Paradis; C de Jaham; N Pagé
Journal:  Can Vet J       Date:  1997-06       Impact factor: 1.008

Review 6.  Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.

Authors:  R J Bertz; G R Granneman
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

7.  Energetic costs of parasitism in the Cape ground squirrel Xerus inauris.

Authors:  M Scantlebury; J M Waterman; M Hillegass; J R Speakman; N C Bennett
Journal:  Proc Biol Sci       Date:  2007-09-07       Impact factor: 5.349

8.  A New Golden Age of Natural Products Drug Discovery.

Authors:  Ben Shen
Journal:  Cell       Date:  2015-12-03       Impact factor: 41.582

9.  In vivo protection against strychnine toxicity in mice by the glycine receptor agonist ivermectin.

Authors:  Ahmed Maher; Rasha Radwan; Hans-Georg Breitinger
Journal:  Biomed Res Int       Date:  2014-09-15       Impact factor: 3.411

Review 10.  Honoring antiparasitics: The 2015 Nobel Prize in Physiology or Medicine.

Authors:  Wei-June Chen
Journal:  Biomed J       Date:  2016-06-06       Impact factor: 4.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.